{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:34:28Z","timestamp":1778916868861,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s10072-013-1393-x","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T01:10:26Z","timestamp":1369098626000},"page":"83-86","source":"Crossref","is-referenced-by-count":7,"title":["Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies"],"prefix":"10.1007","volume":"34","author":[{"given":"G.","family":"Allais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Tullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Omboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pezzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bussone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,22]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ncl.2009.01.002","volume":"27","author":"CL Lay","year":"2009","unstructured":"Lay CL, Broner SW (2009) Migraine in women. Neurol Clin 27:503\u2013511","journal-title":"Neurol Clin"},{"issue":"Suppl 1","key":"1393_CR2","first-page":"9","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edn. Cephalalgia 24(Suppl 1):9\u2013160","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"1393_CR3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s10072-009-0051-9","volume":"30","author":"G Allais","year":"2009","unstructured":"Allais G, Gabellari IC, Airola G, Borgogno P, Schiapparelli P, Benedetto C (2009) Headache induced by the use of combined oral contraceptives. Neurol Sci 30(Suppl 1):S15\u2013S17","journal-title":"Neurol Sci"},{"key":"1393_CR4","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2165\/11538090-000000000-00000","volume":"70","author":"EA MacGregor","year":"2010","unstructured":"MacGregor EA (2010) Prevention and treatment of menstrual migraine. Drugs 70:1799\u20131818","journal-title":"Drugs"},{"key":"1393_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/tcrm.2006.2.3.303","volume":"2","author":"EA Balbisi","year":"2006","unstructured":"Balbisi EA (2006) Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine. Ther Clin Risk Manag 2:303\u2013308","journal-title":"Ther Clin Risk Manag"},{"issue":"Suppl 1","key":"1393_CR6","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s10072-012-1044-7","volume":"33","author":"G Allais","year":"2012","unstructured":"Allais G, Tullo V, Omboni S, Benedetto C, Sances G, Zava D, Ferrari MD, Bussone G (2012) Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies. Neurol Sci 33(Suppl 1):S65\u2013S69","journal-title":"Neurol Sci"},{"key":"1393_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/11209380-000000000-00000","volume":"26","author":"M Sanford","year":"2012","unstructured":"Sanford M (2012) Frovatriptan: a review of its use in the acute treatment of migraine. CNS Drugs 26:791\u2013811","journal-title":"CNS Drugs"},{"key":"1393_CR8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","volume":"78","author":"SD Silberstein","year":"2012","unstructured":"Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E, Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society (2012) Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards subcommittee of the American academy of neurology and the American headache society. Neurology 78:1337\u20131345","journal-title":"Neurology"},{"issue":"Suppl 2","key":"1393_CR9","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1007\/s10194-012-0437-6","volume":"13","author":"P Sarchielli","year":"2012","unstructured":"Sarchielli P, Granella F, Prudenzano MP, Pini LA, Guidetti V, Bono G, Pinessi L, Alessandri M, Antonaci F, Fanciullacci M, Ferrari A, Guazzelli M, Nappi G, Sances G, Sandrini G, Savi L, Tassorelli C, Zanchin G (2012) Italian guidelines for primary headaches: 2012 revised version. J Headache Pain 13(Suppl 2):S31\u2013S70","journal-title":"J Headache Pain"},{"key":"1393_CR10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1526-4610.2012.02185.x","volume":"52","author":"E Loder","year":"2012","unstructured":"Loder E, Burch R, Rizzoli P (2012) The 2012 AHS\/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache 52:930\u2013945","journal-title":"Headache"},{"issue":"Suppl 1","key":"1393_CR11","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1007\/s10072-008-0921-6","volume":"29","author":"G Allais","year":"2008","unstructured":"Allais G, Bussone G, Airola G, Borgogno P, Gabellari IC, De Lorenzo C, Pavia E, Benedetto C (2008) Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan. Neurol Sci 29(Suppl 1):S186\u2013S190","journal-title":"Neurol Sci"},{"key":"1393_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10194-010-0243-y","volume":"12","author":"L Savi","year":"2011","unstructured":"Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. J Headache Pain 12:219\u2013226","journal-title":"J Headache Pain"},{"key":"1393_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10194-011-0325-5","volume":"12","author":"M Bartolini","year":"2011","unstructured":"Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Brighina F, Fierro B (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain 12:361\u2013368","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"1393_CR14","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1007\/s10072-010-0273-x","volume":"31","author":"V Tullo","year":"2010","unstructured":"Tullo V, Allais G, Ferrari MD, Curone M, Mea E, Omboni S, Benedetto C, Zava D, Bussone G (2010) Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci 31(Suppl 1):S51\u2013S54","journal-title":"Neurol Sci"},{"key":"1393_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/01.WNL.0000134620.30129.D6","volume":"63","author":"SD Silberstein","year":"2004","unstructured":"Silberstein SD, Elkind AH, Schreiber C, Keywood C (2004) A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 63:261\u2013269","journal-title":"Neurology"},{"key":"1393_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10194-007-0417-4","volume":"8","author":"M Guidotti","year":"2007","unstructured":"Guidotti M, Mauri M, Barril\u00e0 C, Guidotti F, Belloni C (2007) Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of mestrual migraine. J Headache Pain 8:283\u2013288","journal-title":"J Headache Pain"},{"key":"1393_CR17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1526-4610.2009.01513.x","volume":"49","author":"EA MacGregor","year":"2009","unstructured":"MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S (2009) Safety and tolerability of short-term preventive frovatriptan: a combined analysis. Headache 49:1298\u20131314","journal-title":"Headache"},{"key":"1393_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1056\/NEJMct0910887","volume":"363","author":"E Loder","year":"2010","unstructured":"Loder E (2010) Triptan therapy in migraine. N Engl J Med 363:63\u201370","journal-title":"N Engl J Med"},{"key":"1393_CR19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/09513590.2010.487607","volume":"26","author":"F Facchinetti","year":"2010","unstructured":"Facchinetti F, Allais G, Nappi RE, Gabellari IC, Di Renzo GC, Genazzani AR, Bellafronte M, Roncolato M, Benedetto C (2010) Sumatriptan (50\u00a0mg tablets vs. 25\u00a0mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study. Gynecol Endocrinol 26:773\u2013779","journal-title":"Gynecol Endocrinol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-013-1393-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1393-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:52:18Z","timestamp":1553626338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-013-1393-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":19,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s10072-013-1393-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}